share_log

PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Boesgaard Lars

SEC ·  Dec 5, 2023 07:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more